Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric protein in the treatment of amyloidosis

Chimeric protein in the treatment of amyloidosis

US Patent 12291552 · Granted May 6, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of modified Fc fragments in immunotherapy2025
Fc mutants with modified functional activity2023
Chimeric protein in the treatment of amyloidosis2022
Chimeric protein in the treatment of amyloidosis2022
Cell line overexpressing human CD303 antigen2019
Monoclonal antibodies with enhanced ADCC function2018
Use of ADCC-optimized antibodies for treating low-responder patients2018
Antibody method for treatment of a disease in which the target cells are cells w2018
Monoclonal antibodies with enhanced ADCC function2017
Monoclonal antibodies with enhanced ADCC function2017
Recombinant anti-MUC1 antibodies2017
Monoclonal antibody directed against CD20 antigen2016